Literature DB >> 24493024

Genetics of breast cancer bone metastasis: a sequential multistep pattern.

Hassan Fazilaty1, Parvin Mehdipour.   

Abstract

Bone metastasis accounts for the vast majority of breast cancer (BC) metastases, and is related to a high rate of morbidity and mortality. A number of seminal studies have uncovered gene expression signatures involved in BC development and bone metastasis; each of them points at a distinct step of the 'invasion-metastasis cascade'. In this review, we provide most recently discovered functions of sets of genes that are selected from widely accepted gene signatures that are implicate in BC progression and bone metastasis. We propose a possible sequential pattern of gene expression that may lead a benign primary breast tumor to get aggressiveness and progress toward bone metastasis. A panel of genes which primarily deal with features like DNA replication, survival, proliferation, then, angiogenesis, migration, and invasion has been identified. TGF-β, FGF, NFκB, WNT, PI3K, and JAK-STAT signaling pathways, as the key pathways involved in breast cancer development and metastasis, are evidently regulated by several genes in all three signatures. Epithelial to mesenchymal transition that is also an important mechanism in cancer stem cell generation and metastasis is evidently regulated by these genes. This review provides a comprehensive insight regarding breast cancer bone metastasis that may lead to a better understanding of the disease and take step toward better treatments.

Entities:  

Mesh:

Year:  2014        PMID: 24493024     DOI: 10.1007/s10585-014-9642-9

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  294 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

Review 2.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

3.  Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.

Authors:  F Farabegoli; C Ceccarelli; D Santini; M Taffurelli
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

4.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice.

Authors:  Rocío Sotillo; Eva Hernando; Elena Díaz-Rodríguez; Julie Teruya-Feldstein; Carlos Cordón-Cardo; Scott W Lowe; Robert Benezra
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

5.  Role of L2DTL, cell cycle-regulated nuclear and centrosome protein, in aggressive hepatocellular carcinoma.

Authors:  Hung-Wei Pan; Han-Yi E Chou; Shu-Hsiang Liu; Shian-Yang Peng; Chao-Lien Liu; Hey-Chi Hsu
Journal:  Cell Cycle       Date:  2006-11-15       Impact factor: 4.534

6.  TOM1L is involved in a novel signaling pathway important for the IL-2 production in Jurkat T cells stimulated by CD3/CD28 co-ligation.

Authors:  Ahmed Elmarghani; Hanan Abuabaid; Peter Kjellen
Journal:  Mediators Inflamm       Date:  2010-02-21       Impact factor: 4.711

7.  FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities.

Authors:  S Allerstorfer; G Sonvilla; H Fischer; S Spiegl-Kreinecker; C Gauglhofer; U Setinek; T Czech; C Marosi; J Buchroithner; J Pichler; R Silye; T Mohr; K Holzmann; B Grasl-Kraupp; B Marian; M Grusch; J Fischer; M Micksche; W Berger
Journal:  Oncogene       Date:  2008-03-24       Impact factor: 9.867

8.  Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway.

Authors:  Lihua Ding; Zhaoyun Wang; Jinghua Yan; Xiao Yang; Aijun Liu; Weiyi Qiu; Jianhua Zhu; Juqiang Han; Hao Zhang; Jing Lin; Long Cheng; Xi Qin; Chang Niu; Bin Yuan; Xiaohui Wang; Cui Zhu; Yan Zhou; Jiezhi Li; Haifeng Song; Cuifen Huang; Qinong Ye
Journal:  J Clin Invest       Date:  2009-01-12       Impact factor: 14.808

9.  Heterogeneity in cancer: cancer stem cells versus clonal evolution.

Authors:  Mark Shackleton; Elsa Quintana; Eric R Fearon; Sean J Morrison
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

10.  Hypoxia-inducible factor-1 transactivates transforming growth factor-beta3 in trophoblast.

Authors:  Hirotaka Nishi; Toshihide Nakada; Mitsuyasu Hokamura; Yumi Osakabe; Osamu Itokazu; L Eric Huang; Keiichi Isaka
Journal:  Endocrinology       Date:  2004-05-20       Impact factor: 4.736

View more
  12 in total

Review 1.  Pathogenesis of Breast Cancer Metastasis to Brain: a Comprehensive Approach to the Signaling Network.

Authors:  Bahrami Tayyeb; Mehdipour Parvin
Journal:  Mol Neurobiol       Date:  2014-12-04       Impact factor: 5.590

2.  SLUG and SOX9 Cooperatively Regulate Tumor Initiating Niche Factors in Breast Cancer.

Authors:  Hassan Fazilaty; Mossa Gardaneh; Parvin Akbari; Ali Zekri; Babak Behnam
Journal:  Cancer Microenviron       Date:  2015-09-28

3.  Protein-tyrosine pseudokinase 7 (PTK7) directs cancer cell motility and metastasis.

Authors:  Vladislav S Golubkov; Natalie L Prigozhina; Yong Zhang; Konstantin Stoletov; John D Lewis; Phillip E Schwartz; Robert M Hoffman; Alex Y Strongin
Journal:  J Biol Chem       Date:  2014-07-08       Impact factor: 5.157

4.  IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study.

Authors:  Jung-Ta Kao; Chun-Lung Feng; Cheng-Ju Yu; Shu-Mei Tsai; Ping-Ning Hsu; Yao-Li Chen; Yi-Ying Wu
Journal:  BMC Gastroenterol       Date:  2015-04-25       Impact factor: 3.067

5.  The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancer.

Authors:  Nigel T Brockton; Stephanie J Gill; Stephanie L Laborge; Alexander H G Paterson; Linda S Cook; Hans J Vogel; Carrie S Shemanko; David A Hanley; Anthony M Magliocco; Christine M Friedenreich
Journal:  BMC Cancer       Date:  2015-07-10       Impact factor: 4.430

Review 6.  Engineering 3D approaches to model the dynamic microenvironments of cancer bone metastasis.

Authors:  Han Qiao; Tingting Tang
Journal:  Bone Res       Date:  2018-02-26       Impact factor: 13.567

7.  miRNA-148a and miRNA-30c expressions as potential biomarkers in breast cancer patients.

Authors:  Nesreen G Elhelbawy; Ibrahim F Zaid; Aya A Khalifa; Suzy F Gohar; Eman A Fouda
Journal:  Biochem Biophys Rep       Date:  2021-06-21

Review 8.  Cytokines as Mediators of Pain-Related Process in Breast Cancer.

Authors:  Carolina Panis; Wander Rogério Pavanelli
Journal:  Mediators Inflamm       Date:  2015-11-09       Impact factor: 4.711

Review 9.  Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?

Authors:  Sandra Casimiro; Arlindo R Ferreira; André Mansinho; Irina Alho; Luis Costa
Journal:  Int J Mol Sci       Date:  2016-08-27       Impact factor: 5.923

Review 10.  In Vitro Co-Culture Models of Breast Cancer Metastatic Progression towards Bone.

Authors:  Chiara Arrigoni; Simone Bersini; Mara Gilardi; Matteo Moretti
Journal:  Int J Mol Sci       Date:  2016-08-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.